论文部分内容阅读
美国国会用了一周的时间将其注意力集中在生物技术上(包括一次开了一整天的会议及有关一项法案的听证会,法案内容是建立旨在增强生物工程行业的竞争力的各委员会),而其高潮则是上周发表的一份由美国技术评价局(OTA)准备的报告。该报告题为“美国对生物技术的投资”,这是自八十年代初生物技术行业在美国真正发展起来以后对美国为促进生物技术的发展并消除在其发展过程中来自联邦政府的障碍而作的
It took the United States Congress a week to focus its attention on biotechnology (including a full day of meetings and hearings on a bill that was designed to build on the competitiveness of the bioengineering industry Committee), culminating in a report prepared by the U.S. Agency for Technical Evaluation (OTA) last week. The report, titled “U.S. Investment in Biotechnology,” is about the U.S. impediment to the development of biotechnology since the real development of the biotechnology industry in the United States in the early 1980s and the removal of the federal government's impediments to its development Made of